MacroGenics
MGNX
#8323
Rank
โ‚น24.86 B
Marketcap
โ‚น391.11
Share price
4.29%
Change (1 day)
202.82%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): -โ‚น4.98

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น4.73. In 2024 the company made an earnings per share (EPS) of -โ‚น101.33 a decrease over its 2023 EPS that were of -โ‚น14.20.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น4.98-95.09%
2024-โ‚น101.33613.33%
2023-โ‚น14.20-92.31%
2022-โ‚น184.66-42.14%
2021-โ‚น319.1436.44%
2020-โ‚น233.91-21.84%
2019-โ‚น299.25-24.58%
2018-โ‚น396.79675.93%
2017-โ‚น51.14-68.05%
2016-โ‚น160.04168.25%
2015-โ‚น59.66-55%
2014-โ‚น132.583400%
2013-โ‚น3.79-108.68%
2012โ‚น43.6524.49%
2011โ‚น35.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น124.06-2,720.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,673-56,550.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,371-29,060.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น648.69-13,800.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น336.88-7,214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น337.13-7,220.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น167.62 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA